Literature DB >> 34110493

Overview of the findings and advances in the neurocognitive and psychosocial functioning of mild to moderate pediatric CKD: perspectives from the Chronic Kidney Disease in Children (CKiD) cohort study.

Stephen R Hooper1, Rebecca J Johnson2, Arlene C Gerson3, Marc B Lande4, Shlomo Shinnar5, Lyndsay A Harshman6, Amy J Kogon7, Matthew Matheson8, Sharon Bartosh9, Joann Carlson10, Bradley A Warady11, Susan L Furth7.   

Abstract

The Chronic Kidney Disease in Children (CKiD) prospective cohort study was designed to address the neurocognitive, growth, cardiovascular, and disease progression of children and adolescents with mild to moderate CKD. The study has had continuous funding from NIDDK for 17 years and has contributed significant advances in pediatric CKD. The goals of this educational review are threefold: (1) to provide an overview of the neurocognitive and psychosocial studies from CKiD to date; (2) to provide best practice recommendations for those working with the neurocognitive and psychosocial aspects of pediatric CKD based on CKiD findings; and (3) to help chart future goals and directives for both research and clinical practice. This collection of 22 empirical studies has produced a number of key findings for children and adolescents with mild to moderate CKD. While various studies suggest a relatively positive presentation for this population as a whole, without evidence of significant impairment or deterioration, findings do indicate the presence of neurocognitive dysfunction, emotional-behavioral difficulties, and lower quality of life for many children with CKD. These findings support the promotion of best practices that are accompanied by additional future clinical and research initiatives with this patient population.
© 2021. IPNA.

Entities:  

Keywords:  CKiD study; Emotional-behavioral; Neurocognition; Pediatric CKD; Quality of life

Mesh:

Year:  2021        PMID: 34110493      PMCID: PMC8660930          DOI: 10.1007/s00467-021-05158-w

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.651


  1 in total

1.  Health-related quality of life in children with chronic kidney disease is affected by the number of medications.

Authors:  Maria E Díaz-González de Ferris; Chris B Pierce; Debbie S Gipson; Susan L Furth; Bradley A Warady; Stephen R Hooper
Journal:  Pediatr Nephrol       Date:  2021-02-05       Impact factor: 3.714

  1 in total
  5 in total

1.  Differential Attention Functioning in Pediatric Chronic Kidney Disease.

Authors:  Peter J Duquette; Debbie S Gipson; Stephen R Hooper
Journal:  Front Hum Neurosci       Date:  2022-06-24       Impact factor: 3.473

Review 2.  Functional Magnetic Resonance Imaging Findings in Children and Adolescents With Chronic Kidney Disease: Preliminary Findings.

Authors:  Waverly Harrell; Debbie S Gipson; Aysenil Belger; Mina Matsuda-Abedini; Bruce Bjornson; Stephen R Hooper
Journal:  Semin Nephrol       Date:  2021-09       Impact factor: 4.472

3.  The Similarities and Differences Between Glomerular vs. Non-glomerular Diagnoses on Intelligence and Executive Functions in Pediatric Chronic Kidney Disease: A Brief Report.

Authors:  Stephen R Hooper; Rebecca J Johnson; Marc Lande; Matthew Matheson; Shlomo Shinnar; Amy J Kogon; Lyndsay Harshman; Joann Spinale; Arlene C Gerson; Bradley A Warady; Susan L Furth
Journal:  Front Neurol       Date:  2021-12-20       Impact factor: 4.003

4.  The Burden of Mental Health Conditions in Children With CKD.

Authors:  Katherine L Kurzinski; Darcy K Weidemann
Journal:  Kidney Med       Date:  2022-05-02

5.  The Association of Aspartate Aminotransferase/Alanine Aminotransferase Ratio with Diabetic Nephropathy in Patients with Type 2 Diabetes.

Authors:  Jing Xu; Xiaomin Shi; Youjin Pan
Journal:  Diabetes Metab Syndr Obes       Date:  2021-09-07       Impact factor: 3.168

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.